ArticleInternational urology and nephrology2026
Bladder tumors in patients initially diagnosed with interstitial cystitis: a ten-year retrospective study.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInterstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic inflammatory condition characterized by bladder pain and lower urinary tract symptoms. As a diagnosis of exclusion, IC/BPS shares overlapping features with bladder tumors, which may lead to misdiagnosis or delayed diagnosis. Clinical evidence regarding the relationship between IC/BPS and bladder tumors remains limited.
methodsIn this single-center retrospective study, 863 patients initially diagnosed with IC/BPS who underwent cystoscopic hydrodistension with random multi-site bladder biopsies between January 2015 and June 2025 were reviewed. Twenty-five patients who were subsequently diagnosed with bladder cancer or nephrogenic adenoma based on initial or repeated biopsies were included. Clinical, imaging, cystoscopic, pathological, treatment, and follow-up data were analyzed.
resultsThe cohort included 15 males and 10 females, with a median age of 56 years. The most common initial symptoms were urinary frequency, urgency, and dysuria. Hematuria developed in eight patients during disease progression. Imaging frequently showed bladder wall thickening without definite mass lesions. Cystoscopic findings were heterogeneous, ranging from diffuse inflammatory changes to tumor-like lesions. Fourteen patients were diagnosed at initial biopsy, while others were diagnosed after repeated biopsies. Twelve patients underwent radical cystectomy. During a median follow-up of 48 months, recurrence and metastasis rates were low. Oncologic outcomes should be interpreted cautiously because follow-up was incomplete and heterogeneous.
conclusionA subset of patients initially diagnosed with IC/BPS may harbor or develop bladder tumors. Close surveillance and repeated cystoscopic multi-site biopsies are recommended, particularly in high-risk patients such as males and those with hematuria, to improve early detection and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.